Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 6492-6502

  Parks, Christine G ^a   Miller, Frederick W ^a   Satoh, Minoru ^b   Chan, Edward K L ^c   Andrushchenko, Zhanna ^d   Birnbaum, Linda S ^a   Jusko, Todd A ^e   Kissling, Grace E ^a   Patel, Mehul D ^f   Rose, Kathryn M ^d   Weinberg, Clarice ^a   Zeldin, Darryl C ^a   Sandler, Dale P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF FLORIDA   (United States)

^d SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; ESTROGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; BIRTH; BREAST FEEDING; CHILD; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEALTH SURVEY; HUMAN; MENARCHE; MENOPAUSE; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NULLIPARA; PARITY; POSTMENOPAUSE; PREVALENCE; REPRODUCTION; REPRODUCTIVE HISTORY; RISK FACTOR; UNITED STATES; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; CHILD; FEMALE; HORMONES; HUMANS; MIDDLE AGED; REPRODUCTIVE HISTORY; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84920132478     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0429     Document Type: Article

References (67)

1. Zaenker P, Ziman MR. Serologic autoantibodies as diagnostic cancer biomarkers - a review. Cancer Epidemiol Biomarkers Prev 2013;22:2161-81.
2. Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 2008;222:328-40.
3. Hanash S. Harnessing the immune response for cancer detection. Cancer Epidemiol Biomarkers Prev 2011;20:569-70.
4. Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 2011;8:142-50.
5. Vella LA, Yu M, Fuhrmann SR, El-Amine M, Epperson DE, Finn OJ. Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proc Natl Acad Sci U S A 2009;106:14010-5.
6. Nolen B, Winans M, Marrangoni A, Lokshin A. Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. J Immunol Methods 2009;344:116-20.
7. Pinheiro SP, Hankinson SE, Tworoger SS, Rosner BA, McKolanis JR, Finn OJ, et al. Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 2010;19:1595-601.
8. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
9. Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y. Natural autoantibodies in the serum of healthy women - a five-year follow-up. Clin Exp Immunol 1989;75:402-6.
10. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol 1999;26:914-9.
11. Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012;64:2319-27.
12. Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH. Autoimmunity in a rural community. Clin Exp Immunol 1972;12:79-87.
13. Njemini R, Meyers I, Demanet C, Smitz J, Sosso M, Mets T. The prevalence of autoantibodies in an elderly sub-Saharan African population. Clin Exp Immunol 2002;127:99-106.
14. Ishikawa M, Konta T, Hao Z, Takasaki S, Abiko H, Takahashi T, et al. Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study. Clin Exp Nephrol 2008;12:200-6.
15. Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun 2012;38:J282-91.
16. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012;38:J109-19.
17. Chan EK, Fritzler MJ, Wiik A, Andrade LE, Reeves WH, Tincani A, et al. AutoAbSC.Org - Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007;6:577-80.
18. Korn EL, Graubard BI. Analysis of Health Surveys. New York, NY: John Wiley & Sons; 1999.
19. Li WH, Zhao J, Li HY, Liu H, Li AL, Wang HX, et al. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing. Proteomics 2006;6:4781-9.
20. Bracci PM, Zhou M, Young S, Wiemels J. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Cancer 2012;118:5384-94.
21. Wiemels JL, Bracci PM, Wrensch M, Schildkraut J, Bondy M, Pfefferle J, et al. Assessment of autoantibodies to meningioma in a population-based study. Am J Epidemiol 2013;177:75-83.
22. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010;9:A259-66.
23. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13:R30.
24. Olsen NJ, Li QZ, Quan J, Wang L, Mutwally A, Karp DR. Autoantibody profiling to follow evolution of lupus syndromes. Arthritis Res Ther 2012;14:R174.
25. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011;63:191-200.
26. Carp HJ, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012;38:J266-74.
27. Jorgensen KT, Pedersen BV, Nielsen NM, Jacobsen S, Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2012;38:J81-7.
28. Khashan AS, Kenny LC, Laursen TM, Mahmood U, Mortensen PB, Henriksen TB, et al. Pregnancy and the risk of autoimmune disease. PLoS ONE 2011;6:e19658.
29. Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev 2012;11:A502-14.
30. Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev 2012;11:A465-70.
31. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol 2012;33:421-7.
32. Fugazzola L, Cirello V, Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol 2011;7:89-97.
33. Gammill HS, Guthrie KA, Aydelotte TM, Adams Waldorf KM, Nelson JL. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood 2010;116:2706-12.
34. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy. J Autoimmun 2010;34:J287-99.
35. Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatology 2008;47 Suppl 3:iii2-5.
36. Ghosh M, Rodriguez-Garcia M, Wira CR. The immune system in menopause: pros and cons of hormone therapy. J Steroid Biochem Mol Biol 2014;142:171-5.
37. Cunningham M, Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 2011;40:66-73.
38. Chighizola C, Meroni PL. The role of environmental estrogens and autoimmunity. Autoimmun Rev 2012;11:A493-501.
39. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-74.
40. Sakiani S, Olsen NJ, Kovacs WJ. Gonadal steroids and humoral immunity. Nat Rev Endocrinol 2013;9:56-62.
41. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.
42. Clancy KB, Klein LD, Ziomkiewicz A, Nenko I, Jasienska G, Bribiescas RG. Relationships between biomarkers of inflammation, ovarian steroids, and age at menarche in a rural polish sample. Am J Hum Biol 2013;25:389-98.
43. D'Aloisio AA, DeRoo LA, Baird DD, Weinberg CR, Sandler DP. Prenatal and infant exposures and age at menarche. Epidemiology 2013;24:277-84.
44. Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study. Br J Cancer 2010;103:1760-4.
45. Kwok MK, Leung GM, Lam TH, Schooling CM. Early life infections and onset of puberty: evidence from Hong Kong's children of 1997 birth cohort. Am J Epidemiol 2011;173:1440-52.
46. Boynton-Jarrett R, Harville EW. A prospective study of childhood social hardships and age at menarche. Ann Epidemiol 2012;22:731-7.
47. Bellinger DL, Lubahn C, Lorton D. Maternal and early life stress effects on immune function: relevance to immunotoxicology. J Immunotoxicol 2008;5:419-44.
48. Gogal RM Jr, Holladay SD. Perinatal TCDD exposure and the adult onset of autoimmune disease. J Immunotoxicol 2008;5:413-8.
49. Simard JF, Karlson EW, Costenbader KH, Hernan MA, Stampfer MJ, Liang MH, et al. Perinatal factors and adult-onset lupus. Arthritis Rheum 2008;59:1155-61.
50. Parks CG, D'Aloisio AA, DeRoo LA, Huiber K, Rider LG, Miller FW, et al. Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood. Ann RheumDis 2013;72:350-6.
51. Walitt BT, Constantinescu F, Katz JD, Weinstein A, Wang H, Hernandez RK, et al. Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: the Women's Health Initiative. J Rheumatol 2008;35:811-8.
52. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003;48:917-26.
53. Brix TH, Kyvik KO, Hegedus L. Validity of self-reported hyperthyroidism and hypothyroidism: comparison of self-reported questionnaire data with medical record review. Thyroid 2001;11:769-73.
54. Annonymous. [cited 2014 July 8]. Available from: http://www.cdc.gov/nchs/nhanes/response-rates-CPS.
55. Navarra SV, Ishimori MI, Uy EA, Hamijoyo L, Sama J, James JA, et al. Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus 2011;20:537-43.
56. Laustrup H, Heegaard NH, Voss A, Green A, Lillevang ST, Junker P. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus 2004;13:792-9.
57. Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006;7:417-32.
58. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 2002;46:1830-9.
59. Jorgensen KT, Nielsen NM, Pedersen BV, Jacobsen S, Frisch M. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 2012;38:J120-8.
60. Pike MC, Ross RK, Spicer DV. Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol 1998;147:718-21.
61. Rosner B, Colditz GA. Age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer. Ann Epidemiol 2011;21:450-60.
62. Rockhill B, Colditz GA, Rosner B. Bias in breast cancer analyses due to error in age at menopause. Am J Epidemiol 2000;151:404-8.
63. Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol 2011;118:1271-9.
64. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012;166:765-78.
65. Mendola P, Messer LC, Rappazzo K. Science linking environmental contaminant exposures with fertility and reproductive health impacts in the adult female. Fertil Steril 2008;89:e81-94.
66. Cutolo M, Paolino S, Sulli A, Smith V, Pizzorni C, Seriolo B. Vitamin D, steroid hormones, and autoimmunity. Ann N Y Acad Sci 2014;1317:39-46.
67. Chao T, Ladd JJ, Qiu J, Johnson MM, Israel R, Chin A, et al. Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy. Proteomics Clin Appl 2013;7:327-36.